Illumina to Divest Itself of Cancer-Test Maker Grail
Wall Street Journal
The gene-sequencing company said its goal was to complete the divestiture by the middle of 2024.
https://www.wsj.com/articles/illumina-to-divest-itself-of-cancer-test-maker-grail-3f74f1e8